FCPA

The annual report released by the SEC Office of the Whistleblower for the 2015 fiscal year showed an increase in Foreign…

At yesterday's session of CBI's Pharmaceutical Compliance Conference in Washington, DC, Andrew Ceresney, Director of Enforcement…

Bio-Rad Labs recently agreed to pay a $14.35 million dollar penalty to resolve DOJ allegations that its subsidiaries…

In July of last year, Chinese authorities accused GlaxoSmithKline (GSK) of using a network of travel agencies to channel around…

The Chinese bribery allegations against GlaxoSmithKline (GSK) have taken a scary turn for pharmaceutical executives…

The Securities and Exchange Commission (SEC) charged Stryker Corp. with violating the Foreign Corrupt Practices Act (FCPA) when…

Recent articles have focused on the story of China baring GlaxoSmithKline executive from leaving the country as it turns up the…

As we have written several times over the past couple of years, the Department of Justice (DOJ) and the Securities and Exchange…

Investigating and prosecuting private companies who’s global employees on bribery has proven to be a growth industry.…

Over the past few years, the focus on the life sciences industry has increased dramatically, including cases under not only the…